Peter K. Kaiser
Corporate Officer/Principal bei OCULAR THERAPEUTIX, INC.
Profil
Peter K.
Kaiser is the founder of SKS Ocular LLC.
He currently holds the position of Director-DOCTR at Cole Eye Institute.
Additionally, he is the Chief Development Officer at Ocular Therapeutix, Inc. starting in 2024.
He is also a Member of Macula Society, American Ophthalmological Society, and The Retina Society.
Previously, he worked as the Senior Vice President-Product Development at Ohr Pharmaceutical, Inc. Dr. Kaiser's education includes an undergraduate degree from Harvard Medical School, a doctorate degree from Harvard Medical School, and an undergraduate degree from Harvard College.
Aktive Positionen von Peter K. Kaiser
| Unternehmen | Position | Beginn |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Corporate Officer/Principal | 22.02.2024 |
| Cole Eye Institute | Corporate Officer/Principal | - |
| The Retina Society | Corporate Officer/Principal | - |
| Macula Society | Corporate Officer/Principal | - |
American Ophthalmological Society
 American Ophthalmological Society Miscellaneous Commercial ServicesCommercial Services The American Ophthalmological Society is an organization that aims to promote excellence in patient care, education, and research in the field of ophthalmology. The society is based in San Francisco, CA, and was founded in 1864 by Edward Delafield, Daniel Bennett St. John Roosa, and Henry Noyes. The private company addresses essential issues in medicine and advance the art and science of ophthalmology. The society holds annual meetings every third week of May each year, and they offer travel grants to non-members who wish to attend. Membership nominations are accepted until April 30th each year. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Peter K. Kaiser
| Unternehmen | Position | Ende |
|---|---|---|
SKS Ocular LLC
 SKS Ocular LLC BiotechnologyHealth Technology SKS Ocular, LLC is a private ophthalmology company incubator that uses state-of-the-art research and development technologies to discover and advance novel therapeutics through preclinical or clinical proof of concept. | Gründer | - |
Ohr Pharmaceutical, Inc.
 Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Ausbildung von Peter K. Kaiser
| Harvard Medical School | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OCULAR THERAPEUTIX, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
| Macula Society | |
American Ophthalmological Society
American Ophthalmological Society Miscellaneous Commercial ServicesCommercial Services The American Ophthalmological Society is an organization that aims to promote excellence in patient care, education, and research in the field of ophthalmology. The society is based in San Francisco, CA, and was founded in 1864 by Edward Delafield, Daniel Bennett St. John Roosa, and Henry Noyes. The private company addresses essential issues in medicine and advance the art and science of ophthalmology. The society holds annual meetings every third week of May each year, and they offer travel grants to non-members who wish to attend. Membership nominations are accepted until April 30th each year. | Commercial Services |
| The Retina Society | |
Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY. | Health Technology |
| Cole Eye Institute | |
SKS Ocular LLC
SKS Ocular LLC BiotechnologyHealth Technology SKS Ocular, LLC is a private ophthalmology company incubator that uses state-of-the-art research and development technologies to discover and advance novel therapeutics through preclinical or clinical proof of concept. | Health Technology |
